Utah Admin. Code R66-2-2 - Definitions
(1) "Advertised Cannabinoid" means a
cannabinoid listed on the product face.
(2) "Appealing to children" means:
(a) has a likeness bearing resemblance to a
cartoon character or fictional character; or
(b) appears to imitate a food or other
product that is typically marketed toward or is appealing to
children.
(3) "Applicant"
means any person or business entity who applies for a cannabis processing
facility license.
(4)
(a) "Artificially derived cannabinoid" means
a chemical substance that is created by a chemical reaction that changes the
molecular structure of any chemical substance derived from the cannabis
plant.
(b) "Artificially derived
cannabinoid" does not include:
(i) a naturally
occurring chemical substance that is separated from the cannabis plant by a
chemical or mechanical extraction process; or
(ii) a cannabinoid that is produced by
decarboxylation from a naturally occurring cannabinoid acid without the use of
a chemical catalyst.
(5) "Batch" means a quantity of:
(a) cannabis extract produced on a particular
date and time, following clean up until the next clean up during which lots of
cannabis are used;
(b) cannabis
product produced on a particular date and time, following clean up until the
next clean up during which cannabis extract is used; or
(c) cannabis flower packaged on a particular
date and time, following clean up until the next clean up during which lots of
cannabis are being used.
(6) "Brand name" means a type of product
manufactured by a particular company under a particular name. "Brand name" does
not mean strains or flavors.
(7)
"Board" means the Cannabis Production Establishment Licensing Advisory Board,
created in Section
4-41a-201.1.
(8) "Cannabinoid isolate" means the same as
the term is defined in Subsection
R66-3-2(11).
(9)
(a)
"Cannabis" means any part of a marijuana plant.
(b) "Cannabis" does not mean, for the
purposes of this rule, industrial hemp.
(10) "Cannabis concentrate" means the product
of any chemical or physical process applied to cannabis biomass that
concentrates or isolates the cannabinoids contained in the biomass.
(11) "Cannabis cultivation byproduct" means
any portion of a cannabis plant that is not intended to be sold as a cannabis
plant product.
(12) "Cannabis
cultivation facility" means a person that:
(a)
possesses cannabis;
(b) grows or
intends to grow cannabis; and
(c)
sells or intends to sell cannabis to a cannabis cultivation facility or to a
cannabis processing facility.
(13) "Cannabis derivative product" means a
product made using cannabis concentrate.
(14) "Cannabis fact panel" means a part of
the label that contains the information described in Subsections
R66-2-15(10)
and R66-2-15(12).
(15) "Cannabis plant product" means any
portion of a cannabis plant intended to be sold by a medical cannabis pharmacy
in a form that is recognizable as a portion of a cannabis plant.
(16) "Cannabis processing facility" means a
person that:
(a) acquires or intends to
acquire cannabis from a cannabis production establishment;
(b) possesses cannabis with the intent to
manufacture a cannabis product;
(c)
manufactures or intends to manufacture a cannabis product from unprocessed
cannabis or a cannabis concentrate; and
(d) sells or intends to sell a cannabis
product to a medical cannabis pharmacy.
(17) "Cannabis processing facility agent"
means an individual who holds a valid cannabis production establishment agent
registration card with a cannabis processing facility designation.
(18) "Cannabis production establishment agent
registration card" means a registration card that the department issues that:
(a) authorizes an individual to act as a
cannabis production establishment agent; and
(b) designates the type of cannabis
production establishment for which an individual may act as an agent.
(19) "COA" means Certificate of
Analysis from an independent cannabis testing laboratory.
(20) "Complaint" means any negative feedback
received from a medical cannabis patient or medical cannabis or industrial hemp
licensee.
(21) "Department" means
the Utah Department of Agriculture and Food.
(22) "Directions for use" means recommended
routes of administration for a medical cannabis treatment and suggested usage
guidelines, and may include:
(a) THC
percentage;
(b) strain
names;
(c) strain dominance;
or
(d) dietary
restrictions.
(23)
"Label" means a written, printed, or graphic display on the immediate container
of a product.
(24) "Labeling" means
a label and other written, printed, or graphic display:
(a) on the product or the product's container
or wrapper; or
(b) accompanying the
product.
(25) "Logo"
means symbols, stylized text, or both that represent a company through a visual
image that can be easily understood and recognized.
(26) "Lot" means the quantity of:
(a) flower produced on a particular date and
time, following clean up until the next clean up during which the same
materials are used; or
(b) trim,
leaves, or other plant matter from cannabis plants produced on a particular
date and time, following clean up until the next clean up.
(27) "Product face" means the part of a label
that is on the outer packaging and most likely to be displayed, presented, or
shown under customary conditions of display for retail sale.
(28) "Total THC" means the sum of the
determined amounts of delta-9-THC and delta-9-THCA, according to the formula:
Total THC = delta-9-THC + (delta-9-THCA x 0.877).
Notes
State regulations are updated quarterly; we currently have two versions available. Below is a comparison between our most recent version and the prior quarterly release. More comparison features will be added as we have more versions to compare.
No prior version found.